“Maternal and Fetal Outcomes among Pregnant Women with Preeclampsia after Receiving either Methyldopa or Methyldopa plus Nifedipine”, TMJ, vol. 33, no. 4, pp. 85–98, Dec. 2022, doi: 10.4314/tmj.v33i4.573.